Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Li, Ya ^a   Li, Jian sheng ^a   Li, Wei wei ^a   Li, Su yun ^a   Tian, Yan ge ^a   Lu, Xiao fan ^a   Jiang, Su li ^a   Wang, Ying ^a  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bufei jianpi; Bufei yishen; Chronic obstructive pulmonary disease; Traditional Chinese medicine; Yiqi zishen

Indexed keywords

AMINOPHYLLINE; BUFEI JIANPI; BUFEI YISHEN; CHINESE DRUG; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; RESPIRATORY TRACT AGENT; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YIQI ZISHEN; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; CHINESE MEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; LUNG; METABOLISM; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INTERLEUKIN-1BETA; LUNG; MALE; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899932216     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-140     Document Type: Article

References (23)

1. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2013) [http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html], Global Initiative for Chronic Obstructive Lung Disease.
2. Tieri P, Termanini A, Bellavista E, Salvioli S, Capri M, Franceschi C. Charting the NF-kappaB pathway interactome map. PLoS One 2012, 7:e32678. 10.1371/journal.pone.0032678, 3293857, 22403694.
3. Baarsma HA, Spanjer AI, Haitsma G, Engelbertink LH, Meurs H, Jonker MR, Timens W, Postma DS, Kerstjens HA, Gosens R. Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease. PLoS One 2011, 6:e25450. 10.1371/journal.pone.0025450, 3184127, 21980461.
4. Zúñiga JE, Groppe JC, Cui Y, Hinck CS, Contreras-Shannon V, Pakhomova ON, Yang J, Tang Y, Mendoza V, López-Casillas F, Sun L, Hinck AP. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. J Mol Biol 2005, 354:1052-1068. 10.1016/j.jmb.2005.10.014, 16289576.
5. Podowski M, Calvi C, Metzger S, Misono K, Poonyagariyagorn H, Lopez-Mercado A, Ku T, Lauer T, McGrath-Morrow S, Berger A, Cheadle C, Tuder R, Dietz HC, Mitzner W, Wise R, Neptune E. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J Clin Invest 2012, 122:229-240. 10.1172/JCI46215, 3248282, 22182843.
6. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007, 132:1311-1321. 10.1378/chest.06-2568, 17934117.
7. Professional Committee of Pulmonary Disease of Internal Medicine Branch, China Association of Chinese Medicine Syndrome diagnostic criteria of traditional Chinese medicine for chronic obstructive pulmonary disease (2011 version). Zhong Yi Za Zhi 2012, 53:177-178. Professional Committee of Pulmonary Disease of Internal Medicine Branch, China Association of Chinese Medicine.
8. Professional Committee of Pulmonary Disease of Internal Medicine Branch, China Association of Chinese Medicine Diagnosis and treatment guideline of traditional Chinese medicine for chronic obstructive pulmonary disease (2011 version). Zhong Yi Za Zhi 2012, 53:80-84. Professional Committee of Pulmonary Disease of Internal Medicine Branch, China Association of Chinese Medicine.
9. Li SY, Li JS, Wang MH, Xie Y, Yu XQ, Sun ZK, Ma LJ, Zhang W, Zhang HL, Cao F, Pan YC. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med 2012, 12:197. 10.1186/1472-6882-12-197, 3528455, 23107470.
10. Li JS, Li Y, Li SY, Wang YY, Deng L, Tian YG, Jiang SL, Wang Y. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Zhong Xi Yi Jie He Xue Bao 2012, 10:1039-1048.
11. Li Y, Wang YY, Li JS, Li SY, Deng L, Tian YG, Jiang SL, Wang Y. Influence and long-term effect of therapy of regulating and supplementing lung and kidney on collagen and matrix metalloproteinase in lung tissue in COPD rats. Beijing Zhong Yi Yao Da Xue Xue Bao 2012, 35:615-619.
12. Li SY, Li Y, Li JS, Deng L, Tian YG, Jiang SL, Wang Y. Efficacy and long-term effect of three therapies of invigorating lung and kidney for rat with stable COPD. Zhonghua Zhong Yi Yao Za Zhi 2012, 27:3116-3121.
13. Li Y, Li SY, Li JS, Deng L, Tian YG, Jiang SL, Wang Y, Wang YY. A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection. Biol Pharm Bull 2012, 35:1752-1760. 10.1248/bpb.b12-00407, 22863994.
14. Wright JL, Churg A. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev Respir Med 2010, 4:723-734. 10.1586/ers.10.68, 21128748.
15. Wright JL, Churg A. A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest 2002, 121(5 Suppl):188S-191S.
16. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008, 295:L1-15. 10.1152/ajplung.90200.2008, 2494776, 18456796.
17. Liu ZB, Song NN, Geng WY, Jin WZ, Li L, Cao YX, Qian Y, Zhu DN, Shen LL. Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol 2010, 37:963-968. 10.1111/j.1440-1681.2010.05411.x, 20528981.
18. Huang JH, Huang XH, Cheng ZY, Zheng QS, Sun RY. Dose conversion among different animals and healthy volunteers in pharmacological study. Zhongguo Lin Chuang Yao Li Xue Yu Zhi Liao Xue 2004, 9:1069-1072.
19. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
20. Chung KF. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:347-354. 71-72, 10.1513/pats.200504-028SR, 2713326, 16267361.
21. Kersul AL, Iglesias A, Ríos T, Noguera A, Forteza A, Serra E, Agustí A, Cosío BG. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2011, 47:176-183.
22. Brown V, Elborn JS, Bradley J, Ennis M. Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res 2009, 10:24. 10.1186/1465-9921-10-24, 2667166, 19296848.
23. Patterson EK, Yao LJ, Ramic N, Lewis JF, Cepinskas G, McCaig L, Veldhuizen RAW, Yamashita CM. Lung-derived mediators induce cytokine production in downstream organs via an NF-κB-dependent. Mediators Inflamm 2013, 2013:586895. 3625542, 23606793.